VERARD
LOE Approachingverard
NDAUNKNOWNUNKNOWN
Approved
Aug 1939
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 11h ago · AI intelligence enriched 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VERARD is a legacy small-molecule drug approved in 1939 with an unknown mechanism of action and unspecified indication. Limited modern clinical data is available for this historic product.
LOE Approaching
As loss of exclusivity approaches, commercial teams are likely minimal and focused on managed decline rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on VERARD offers limited career growth given zero linked job openings and approaching LOE status. This role is suited for mid-career professionals managing portfolio maintenance rather than ambitious early-career growth.
Brand Manager (Maintenance)Field Sales Representative
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.